HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GasAid, Probiotica "From The Makers Of Imodium" Launching Now

This article was originally published in The Tan Sheet

Executive Summary

Maximum Strength GasAid and Probiotica Daily Dietary Supplement, with principal display panels noting both are "from the makers of Imodium," are arriving now in food, drug and mass outlets nationwide, according to McNeil Consumer Healthcare.

You may also be interested in...



Probiotic Infant Use Raises FDA, Food Advisory Committee Concern

FDA expressed concerns regarding a 75-day premarket notification for a probiotic containing Lactobacillus reuteri due to inadequate information on the bacteria's safety in infants and young children. The notification was submitted June 30 by McNeil Consumer Healthcare.

Nestle LC1 Probiotic Supplement Launching With Direct Mail, Print Support

Nestle USA is introducing its first dietary supplement product, Nestle LC1, with print ads and direct mail support expected to break the week of March 5.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS133293

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel